Lab Facility Shortage Could Impede Biomedical Growth in Seattle | GenomeWeb

SEATTLE, Wash.--Demand for specialized biotech and biomedical office space outstrips supplies here in the nation's fifth largest biotechnology center, according to a recent study conducted by the Washing ton Biotechnology and Biomed ical Association. Biotech and medical technology firms in Washington, 90 percent of which are located in the Seattle area, already occupy 4.4 million square feet of facilities. Available space will be absorbed by June 1998, the report projected, forcing start-up and expanding medium-sized firms to locate outside of the Seattle research center hub.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.